Verbatim response from Perplexity
For most women needing systemic estrogen, estrogen patches are safer than pills, primarily because they carry a significantly lower risk of blood clots (venous thromboembolism) and may have a lower risk of stroke [1][2][3].
The key difference lies in how the body processes the hormone:
- Pills (Oral): Must pass through the liver before entering the bloodstream. This "first-pass" effect triggers inflammation and increases clotting factors, raising the risk of deep vein thrombosis by approximately 58% within the first 90 days of use [1][7]. Some studies indicate oral estrogen users have about 4 times higher odds of blood clots compared to non-users or patch users [2][8].
- Patches (Transdermal): Deliver estrogen directly into the bloodstream through the skin, bypassing the liver. This prevents the spike in clotting factors, meaning patches generally do not increase blood clot risk at all [1][7][10].
Key Safety Comparison
| Risk Factor | Estrogen Pills (Oral) | Estrogen Patches (Transdermal) |
|---|---|---|
| Blood Clots (VTE) | Higher risk (Relative Risk ~1.6–4.2) [1][2] | No significant increase in risk [1][7] |
| Stroke Risk | Modest increase in ischemic stroke risk [2][7] | No elevated risk with low doses [11][7] |
| Liver Impact | Increases risk for those with liver problems [10] | Safe for liver; bypasses it entirely [10] |
| Inflammation | Increases inflammatory markers [1] | Minimal inflammation [1] |
Important Considerations
While patches are generally safer regarding cardiovascular risks, the "best" choice depends on individual health history:
- Who should prefer patches? Women over 35, smokers, or those with obesity, migraines, or a history of blood clots should strongly consider patches due to the lower clot risk [9][10].
- When might pills be chosen? Pills allow for customizable dosing and may be preferred if a patient needs precise dose adjustments that patches cannot easily provide, though this comes with higher safety risks [1][9].
- Overall Safety: Most doctors prefer patches because of their fewer health risks and side effects, particularly for systemic estrogen therapy [1][18].
Disclaimer: "Safer" is relative to your personal health profile. You should discuss your specific risks (age, smoking status, clotting history) with a clinician to individualize your choice [9].